1402 related articles for article (PubMed ID: 8639063)
1. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
2. [Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version].
Ohashi Y; Tashiro K; Itoyama Y; Nakano I; Sobue G; Nakamura S; Sumino S; Yanagisawa N
No To Shinkei; 2001 Apr; 53(4):346-55. PubMed ID: 11360474
[TBL] [Abstract][Full Text] [Related]
3. [Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study].
Atsuta N; Watanabe H; Ito M; Nakamura R; Senda J; Kato S; Sobue G
Brain Nerve; 2011 May; 63(5):491-6. PubMed ID: 21515929
[TBL] [Abstract][Full Text] [Related]
4. Spanish adaptation of the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R).
Campos TS; Rodríguez-Santos F; Esteban J; Vázquez PC; Mora Pardina JS; Carmona AC
Amyotroph Lateral Scler; 2010 Oct; 11(5):475-7. PubMed ID: 20509746
[TBL] [Abstract][Full Text] [Related]
5. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
de Carvalho M; Swash M
Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
[TBL] [Abstract][Full Text] [Related]
6. Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5.
Maessen M; Post MW; Maillé R; Lindeman E; Mooij R; Veldink JH; van den Berg LH
Amyotroph Lateral Scler; 2007 Apr; 8(2):96-100. PubMed ID: 17453637
[TBL] [Abstract][Full Text] [Related]
7. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of a self-administered version of the ALSFRS-R.
Montes J; Levy G; Albert S; Kaufmann P; Buchsbaum R; Gordon PH; Mitsumoto H
Neurology; 2006 Oct; 67(7):1294-6. PubMed ID: 17030772
[TBL] [Abstract][Full Text] [Related]
9. Natural history of amyotrophic lateral sclerosis. Observations with the Charing Cross Amyotrophic Lateral Sclerosis Rating Scales.
Guiloff RJ; Goonetilleke A
Adv Neurol; 1995; 68():185-98. PubMed ID: 8787229
[TBL] [Abstract][Full Text] [Related]
10. [Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)].
Yamaguchi T; Ohbu S; Saito M; Ito Y; Moriwaka F; Tashiro K; Ohashi Y; Fukuhara S
No To Shinkei; 2004 Jun; 56(6):483-94. PubMed ID: 15328837
[TBL] [Abstract][Full Text] [Related]
11. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial.
Kaufmann P; Levy G; Montes J; Buchsbaum R; Barsdorf AI; Battista V; Arbing R; Gordon PH; Mitsumoto H; Levin B; Thompson JL;
Amyotroph Lateral Scler; 2007 Feb; 8(1):42-6. PubMed ID: 17364435
[TBL] [Abstract][Full Text] [Related]
12. A role for functional classification in the early identification of prognostic factors in ALS.
Rauchway AC; Kaiboriboon K; Bansal SK; Kulkantrakorn K; Guo X; Parks BJ; Hayat GR
Amyotroph Lateral Scler; 2007 Aug; 8(4):214-6. PubMed ID: 17653918
[TBL] [Abstract][Full Text] [Related]
13. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
[TBL] [Abstract][Full Text] [Related]
14. Stratifying disease stages with different progression rates determined by electrophysiological tests in patients with amyotrophic lateral sclerosis.
Liu XX; Zhang J; Zheng JY; Zhang S; Xu YS; Kang DX; Fan DS
Muscle Nerve; 2009 Mar; 39(3):304-9. PubMed ID: 19208412
[TBL] [Abstract][Full Text] [Related]
15. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.
Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M
Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761
[TBL] [Abstract][Full Text] [Related]
16. [Functional scales and motor assessment in amyotrophic lateral sclerosis].
Benaïm C; Desnuelle C; Fournier-Méhouas M
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S131-4S137. PubMed ID: 17128101
[TBL] [Abstract][Full Text] [Related]
17. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation.
Iwata NK; Aoki S; Okabe S; Arai N; Terao Y; Kwak S; Abe O; Kanazawa I; Tsuji S; Ugawa Y
Neurology; 2008 Feb; 70(7):528-32. PubMed ID: 18268244
[TBL] [Abstract][Full Text] [Related]
19. Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis.
De Groot IJ; Post MW; van Heuveln T; Van den Berg LH; Lindeman E
Amyotroph Lateral Scler; 2007 Dec; 8(6):356-61. PubMed ID: 18033593
[TBL] [Abstract][Full Text] [Related]
20. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]